Telangana's Bid to Achieve Positive Investment Growth

Hyderabad continues to be a global center for generic drugs and vaccines despite the fact that Telangana's pharmaceutical industry has seen ups and downs throughout the years due to proactive industry policies, initiatives, and state government actions. With the pharmaceutical industry in India expected to grow to $120-130 billion by 2030, Telangana plays a pivotal role in advancing global healthcare solutions.

- Amguth Raju

Telangana state overcoming various hurdles and challenges is rapidly strengthening its position as a global leader in the life sciences and Active Pharmaceutical Ingredients (API) sectors. In the past year from November 2023 to December 2024, the state government succeeded in attracting investments worth Rs 36,000 crore and Rs 5,260 crore in life sciences and API sectors respectively.

With over 140 projects in the pipeline, these investments in the life sciences sector are set to generate 51,000 direct jobs and an additional 1,50,000 indirect jobs, showcasing the state's exceptional growth trajectory in the coming days ahead. Speaking on this remarkable achievement, Telangana's Industries and Commerce Minister, Duddilla Sridhar Babu, emphasized the state's proactive policies and strategic vision. "Telangana has emerged as the epicentre for global life sciences innovation. This momentum includes both significant investments from new entrants and additional investments by existing companies that recognise the value of expanding in Telangana. This is a testament to the business-friendly approach of our government and the strong ecosystem we have built over decades," Babu stated.

Genome Valley: At the Heart of Innovation

The cornerstone of Telangana's success in the life sciences sector lies in Genome Valley, India's first and largest R&D cluster. This hub continues to attract global industry leaders, driving significant investments and expansions. Over the past year, Genome Valley has witnessed remarkable developments, solidifying its reputation as a global innovation centre for pharmaceuticals and biotechnology.